CYP2C19 Genetic Testing for Oral P2Y12 Inhibitor Therapy
You are currently not logged in to PHD
To view this content, please login to your account, or within the login, click 'Create an Account' for guest access. To access AHA's full array of membership benefits, join or renew today!
Writing Group Chair Naveen Pereira, MD and Vice Chair Sharon Cresci, MD discuss a new scientific statement from the American Heart Association.
Recommended Videos
Real-Life Implementation: Key Takeaways
Logistics Involved with Using Mavacamten
2024 HCM Guideline: Mavacamten and Where it Fits in the Management of Pati...
Insomnia Associated Conditions Medical and Psychiatric
Acute Treatment of Cervical Artery Dissection in Adults
Loading...
Save Video
Video is not available. Please check the URL.